SARS CoV 2 News and Research

RSS
COVID virtual wards in England did not have significant impact on health outcomes

COVID virtual wards in England did not have significant impact on health outcomes

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Effects of post-acute COVID-19 on physical and mental health in women

Effects of post-acute COVID-19 on physical and mental health in women

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

South African study confirms SARS-CoV-2 Omicron less severe than Delta even for unvaccinated

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Study shows how sex disparities in COVID-19 mortality varied over time in New York

Sniffer dogs detect long COVID after 1.5 years

Sniffer dogs detect long COVID after 1.5 years

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Exploring the systemic infection of SARS-CoV-2 in a wild leopard in India

Exploring the systemic infection of SARS-CoV-2 in a wild leopard in India

Quantification of SARS-CoV-2 variants in wastewater samples

Quantification of SARS-CoV-2 variants in wastewater samples

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Framework for understanding cross-country spread of COVID-19 in the context of the globally interconnected economy

Framework for understanding cross-country spread of COVID-19 in the context of the globally interconnected economy

Researchers construct models to predict SARS-CoV-2 mutable and constrained positions

Researchers construct models to predict SARS-CoV-2 mutable and constrained positions

Better global health equality could prevent emergence of future SARS-CoV-2 variants of concern

Better global health equality could prevent emergence of future SARS-CoV-2 variants of concern

Study suggests vaccinated Omicron cases are unlikely to shed infectious virus 10 days after diagnosis or symptom onset

Study suggests vaccinated Omicron cases are unlikely to shed infectious virus 10 days after diagnosis or symptom onset

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

Dexamethasone shown to upregulate innate and adaptive immune responses in COVID-19 acute respiratory distress syndrome patients

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

Study demonstrates that intra-host SARS-CoV-2 variants with reduced infectivity are developed during infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.